Back to results
US 2011/0160221 A1Published application
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
AssigneesArray BioPharma Inc., Genentech, Inc.
InventorsJosef R. Bencsik, James F. Blake, Nicholas C. Kallan, Ian S. Mitchell, Keith L. Spencer, Dengming Xiao, Rui Xu, Christine Chabot, Jun Liang, Brian S. Safina
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Claims44
A compound of Formula I:
- and enantiomers and salts thereof, wherein:
- R1 and R1a are independently selected from H, Me, Et, vinyl, CF3, CHF2 or CH2F;
- R2 is H, OH, OMe or F;
- R2a is H, Me or F;
- R3 is H, Me, Et, or CF3;
- A is
- G is phenyl optionally substituted by one to four Re groups or a 5-6 membered heteroaryl optionally substituted by a halogen;
- R5 and R6 are independently H, OCH3, C3-C6-cycloalkyl optionally substituted with F, OH, C1-C3 alkyl or O(C1-C3 alkyl), 4-6 membered heterocycle optionally substituted with F, OH, C1-C3 alkyl, cyclopropylmethyl or C(═O)(C1-C3 alkyl), or C1-C6-alkyl optionally substituted with one or more groups independently selected from OH, oxo, O(C1-C6-alkyl), CN, F, NH2, NH(C1-C6-alkyl), N(C1-C6-alkyl)2, cyclopropyl, phenyl, imidazolyl, piperidinyl, pyrrolidinyl, morpholinyl, tetrahydrofuranyl, oxetanyl or tetrahydropyranyl,
- or R5 and R6 together with the nitrogen to which they are attached form a 4-7 membered heterocyclic ring optionally substituted with one or more groups independently selected from OH, halogen, oxo, CF3, CH2CF3, CH2CH2OH, O(C1-C3 alkyl), C(═O)CH3, NH2, NHMe, N(Me)2, S(O)2CH3, cyclopropylmethyl and C1-C3 alkyl, or
- Rc is hydrogen and Rd and R6 together with the atoms to which they are attached form a 4 to 6 membered heterocyclic ring having one nitrogen atom;
- Ra and Rb are H,
- or Ra is H, and Rb and R6 together with the atoms to which they are attached form a 5-6 membered heterocyclic ring having one or two ring nitrogen atoms;
- Rc and Rd are H or Me,
- or Rc and Rd together with the atom to which they are attached from a cyclopropyl ring;
- each Re is independently halogen, C1-C6-alkyl, C3-C6-cycloalkyl, O—(C1-C6-alkyl), CF3, OCF3, S(C1-C6-alkyl), CN, OCH2-phenyl, NH2, NO2, NH—(C1-C6-alkyl), N—(C1-C6-alkyl)2, piperidine, pyrrolidine, CH2F, CHF2, OCH2F, OCHF2, OH, SO2(C1-C6-alkyl), C(O)NH2, C(O)NH(C1-C6-alkyl), and C(O)N(C1-C6-alkyl)2;
- m and n are independently 0, 1, 2 or 3 with the proviso that (m+n) must equal 2, 3 or 4;
- and
- p is 0 or 1.
15 more elements
A compound of Formula I:
- and enantiomers and salts thereof, wherein:
- R1 and R1a are independently selected from H, Me, Et, vinyl, CF3, CHF2 or CH2F;
- R2 is H, OH, OMe or F;
- R2a is H, Me or F;
- R3 is H, Me, Et, or CF3;
- A is
- G is phenyl optionally substituted by one to four Re groups or a 5-6 membered heteroaryl optionally substituted by a halogen;
- R5 and R6 are independently H, OCH3, C3-C6-cycloalkyl optionally substituted with F, OH, C1-C3 alkyl or O(C1-C3 alkyl), 4-6 membered heterocycle optionally substituted with F, OH, C1-C3 alkyl, cyclopropylmethyl or C(═O)(C1-C3 alkyl), or C1-C6-alkyl optionally substituted with one or more groups independently selected from OH, oxo, O(C1-C6-alkyl), CN, F, NH2, NH(C1-C6-alkyl), N(C1-C6-alkyl)2, cyclopropyl, phenyl, imidazolyl, piperidinyl, pyrrolidinyl, morpholinyl, tetrahydrofuranyl, oxetanyl or tetrahydropyranyl,
- or R5 and R6 together with the nitrogen to which they are attached form a 4-7 membered heterocyclic ring optionally substituted with one or more groups independently selected from OH, halogen, oxo, CF3, CH2CF3, CH2CH2OH, O(C1-C3 alkyl), C(═O)CH3, NH2, NHMe, N(Me)2, S(O)2CH3, cyclopropylmethyl and C1-C3 alkyl;
- Ra and Rb are H,
- or Ra is H, and Rb and R6 together with the atoms to which they are attached form a 5-6 membered heterocyclic ring having one or two ring nitrogen atoms;
- Rc and Rd are H or Me,
- or Rc and Rd together with the atom to which they are attached from a cyclopropyl ring;
- each Re is independently halogen, C1-C6-alkyl, C3-C6-cycloalkyl, O—(C1-C6-alkyl), CF3, OCF3, S(C1-C6-alkyl), CN, OCH2-phenyl, NH2, NO2, NH—(C1-C6-alkyl), N—(C1-C6-alkyl)2, piperidine, pyrrolidine, CH2F, CHF2, OCH2F, OCHF2, OH, SO2(C1-C6-alkyl), C(O)NH2, C(O)NH(C1-C6-alkyl), and C(O)N(C1-C6-alkyl)2;
- m and n are independently 0, 1 or 2, with the proviso that (m+n) must equal 2, 3 or 4;
- and
- p is 0 or 1.
14 more elements
(canceled)
41-42. (canceled)
Dependencies are inferred from the claim text.